April 4, 2022
Canadian Reproductive Tool for IVF Patients Expands Globally to Become First Fully AI Medtech of its Kind
Matris ™ by Synergyne ART Analytics Inc., enters the next phase to become the world’s first and only artificially intelligent fertility technology of its kind — opening the door for improved pregnancy rates for IVF patients everywhere. World-leading US fertility clinic and foremost research hub, Boston IVF, will take the tool across the border to validate the improvement in the IVF success rates achieved in Canada.